LungCancerRx 🫁💊
@LungCancerRx
✍️ Tweeting #lungcancer updates, educational resources, & research breakthroughs | 🤝 Team @adesaimd @fawziaburous @lungoncdoc | 🫶 #lcsm #ASCO24
ID:1659271271765483548
18-05-2023 18:54:44
1,7K Tweets
625 Followers
162 Following
Follow People
Thank you to Marina K Baine, MD, PhD and the incredible thoracic oncology group at Memorial Sloan Kettering Cancer Center for the invitation to speak as a visiting professor at the #DruckenmillerLungCenter seminar series on our The Shields Lab work with lurbinectedin in #SCLC .
#LCSM SmallCellSMASHERS IU Simon Comprehensive Cancer Center
Stepping up for #lunghealth and #lungcancer this morning with the American Lung Association’s Texas Two-Step!
Honored to lead our MD Anderson Cancer Center team! #lcsm #EndCancer 🏃🏽♂️🫁
High-yield IASLC Academy session this morning 🔥
🔸ACCE(ing) your presentations Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation
🔹Publish or Perish Christian Rolfo
Grateful to the co-chairs & faculty who are volunteering their time and expertise! #lcsm
➡️ Practice changing + paradigm altering news for small cell #lungcancer !
FDA Oncology grants acc. approval to tarlatamab (DLL3 BiTE). ORR 40%, mDOR 9.7mo in pre-treated population. Watch for CRS + ICANS. Much needed advance for SCLC - wow! OncoAlert
fda.gov/drugs/resource…
Laura Book Christine Lovly, MD, PhD Eric K. Singhi, MD Balazs Halmos ASCO OncoAlert MD Anderson Cancer Center EGFR Positive UK ASCOPost Conquer Cancer, the ASCO Foundation Jill Feldman LungCancerRx 🫁💊 Oncology Brothers This exploratory analysis is interesting : onclive.com/view/dr-j-nne-…
🚨🔥OncoAlert Hot off the press.
U.S. FDA granted #accelerated approval to #Tarlatamab -dlle (bispecific T-cell engager targeting #DLL3 and #CD3 )
for #ExtensiveStage #SmallCell #LungCancer with disease progression after platinum-based #Chemotherapy .
👇🏼
fda.gov/drugs/resource…
Christine Lovly, MD, PhD Eric K. Singhi, MD Balazs Halmos ASCO OncoAlert MD Anderson Cancer Center EGFR Resisters EGFR Positive UK ASCOPost Conquer Cancer, the ASCO Foundation Jill Feldman LungCancerRx 🫁💊 👏👏👏 phenomenal work Eric K. Singhi, MD and Balazs Halmos on this piece/practical analysis of the available data. Hopefully we will see updated data on #MARIPOSA (high risk patients) at #ASCO24 ! A poll we did to understand sequencing shortly after ESMO data last year 👇! But it will
🚨 FDA Oncology grants accelerated approval for tarlatamab (DLL3 targeting BiTE molecule) for relapsed es- small cell lung cancer after platinum-based therapy. A win for #lcsm ‼️ Amgen Oncology OncoAlert LungCancerRx 🫁💊
Eric- btw- great timing on getting our The ASCO Post ASCO Daily News piece out on the FLAURA2/MARIPOSA data today! Eric K. Singhi, MD
Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation LungCancerRx 🫁💊 Eric K. Singhi, MD Oncology Brothers OncoDaily H. Jack West, MD Nathan A. Pennell MD, PhD, FASCO Dr Riyaz Shah gilberto lopes Narjust Florez, MD, FASCO Aakash Desai, MD, MPH Alfredo Addeo MD Dr. Amy C. Moore Christian Rolfo Charu Aggarwal, MD, MPH, FASCO Dr. Estela Rodriguez Sandip Patel MD Sanjay Popat Balazs Halmos Dr. Nagla Abdel Karim Lynne Eldridge MD nejm.org/doi/full/10.10…
Grateful to have another option, but this is definitely not a home run
50 % ORR
PFS around 4-5 months
Also not many pt in trial got I/O upfront & unclear how it will change responses etc
With FLAURAishing new frontline combination therapies for EGFR+ mNSCLC yet incomplete data—What to do NOW in clinic? 🆘
Balazs Halmos & I share our thoughts for #ASCODailyNews 👇🏽
dailynews.ascopubs.org/do/deciding-be…
ASCO OncoAlert #lcsm
📣🔥OncoAlert Hot Off The Press.
Just published NEJM
Results of #Checkmate 77T trial of:
#Perioperative #Nivolumab (neoadjuvant nivo + chemo followed by surgery followed by adjuvant nivo) in stage IIA-IIIB #NSCLC showing:
⬆️ #DFS & ⬆️ #PCR
👇🏼
nej.md/3VaMtbX
📣 Join Narjust Florez, MD, FASCO and I as we discuss women & Lung cancer - topics we NEED TO TALK ABOUT MORE!
1) Body image
2) Complimentary medicine
3) Financial toxicity
4) Family dynamics
5) #FlorezLab Pregnancy and Lung CA registry
SIGN UP BELOW : 5/15 at 3PM Lung Cancer Research Foundation